- Home
- / MustGrow Biologics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
MustGrow Biologics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$3.3
2023-01-13
Market Capitalization
$123.9 M
2023-01-13
Revenue
$399 K
FY, 2024
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CAD | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 2.0K | 13.0K | 6.0K | 4.7M | 399.0K | ||
| Cost of goods sold | 97.0K | ||||||
| Gross profit | 2.0K | 13.0K | 6.0K | 4.7M | 302.0K | ||
| Gross profit margin, % | 100.0% | 100.0% | 100.0% | 100.0% | 75.7% | ||
| Operating expense total | 832.0K | 1.1M | 3.1M | 2.6M | 4.5M | 4.4M | 5.4M |
| EBITDA | (830.0K) | (1.1M) | (3.1M) | (2.6M) | (4.5M) | 288.0K | (5.1M) |
| EBITDA margin, % | -41500.0% | -19815.4% | -74700.0% | 6.1% | -1281.7% | ||
| EBIT | (830.0K) | (1.1M) | (3.0M) | (2.6M) | (4.5M) | 288.0K | (5.1M) |
| EBIT margin, % | -41500.0% | -19815.4% | -74700.0% | 6.1% | -1281.7% | ||
| Interest income | 104.0K | 212.0K | 202.0K | ||||
| Interest expense | 40.0K | 46.0K | 46.0K | 52.0K | 10.0K | ||
| Pre tax profit | (1.9M) | (1.5M) | (3.3M) | (3.1M) | (5.6M) | (676.0K) | (4.9M) |
| Net Income | (1.9M) | (1.5M) | (3.3M) | (3.1M) | (5.6M) | (676.0K) | (4.9M) |